Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vein External Support Trial (VEST)

This study has been completed.
Information provided by (Responsible Party):
Vascular Graft Solutions Ltd. Identifier:
First received: August 10, 2011
Last updated: May 18, 2014
Last verified: May 2014

Prospective, multi-center, randomized, controlled pilot study to demonstrate the safety and effectiveness of the VGS Fluent external support device, supporting saphenous vein grafts in patients with coronary heart disease.

Condition Intervention
Coronary Heart Disease
Device: Fluent (VGS Fluent external support device)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Vein External Support Trial

Resource links provided by NLM:

Further study details as provided by Vascular Graft Solutions Ltd.:

Enrollment: 30
Study Start Date: October 2011
Study Completion Date: December 2013
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment
Device applied to saphenous vein graft
Device: Fluent (VGS Fluent external support device)
Fluent external support device applied to saphenous vein graft
No Intervention: Control
Saphenous vein graft without device support


Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Primary Inclusion Criteria:

  1. Patient scheduled for on-pump CABG on clinical grounds
  2. Vein grafts indicated for right and circumflex coronary arteries and LIMA indicated for the LAD on clinical grounds
  3. Native circumflex and right coronary arteries have at least one stenosis in each vessel> 75%

Primary Exclusion Criteria:

  1. Concomitant non-CABG cardiac procedure
  2. Prior peripheral vascular or cardiac surgery
  3. Emergency CABG surgery (cardiogenic shock, inotrophic pressure support, IABP)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01415245

United Kingdom
Royal Brompton Hospital
London, United Kingdom
Harefield Hospital
Middlesex, United Kingdom
The John Radcliffe Hospital
Oxford, United Kingdom
Sponsors and Collaborators
Vascular Graft Solutions Ltd.
  More Information

No publications provided

Responsible Party: Vascular Graft Solutions Ltd. Identifier: NCT01415245     History of Changes
Other Study ID Numbers: CI-01-01
Study First Received: August 10, 2011
Last Updated: May 18, 2014
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on November 25, 2014